Response of huSCID mice reconstituted with lymphocytes from anti-idiotype-treated melanoma patients
- 31 December 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 61 (3) , 332-342
- https://doi.org/10.1016/s0090-1229(05)80005-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.Journal of Clinical Investigation, 1990
- Revised immune network conceptsClinical Immunology and Immunopathology, 1989
- Murjne Anti‐Idiotypic Monoclonal Antibodies to Syngeneic Antihuman High Molecular Weight‐Melanoma Associated Antigen Monoclonal Antibodies: Development, Characterization, and Clinical ApplicationsPigment Cell Research, 1988
- Transfer of a functional human immune system to mice with severe combined immunodeficiencyNature, 1988
- Anti-idiotype immunization of cancer patients: modulation of the immune response.Proceedings of the National Academy of Sciences, 1987
- Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodiesInternational Journal of Cancer, 1981